Moleculin Biotech
Price & Volume
Stats
See more52W Range | $1.79-$24 |
Market Cap | $14.3M |
Shares Short | 527,786 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$16.16 |
News
See moreYahoo Finance • 24 hours ago
Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits
Yahoo Finance • 2 months ago
Moleculin to Present at 38th Annual ROTH Conference
Yahoo Finance • 6 months ago
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
Yahoo Finance • 6 months ago
Moleculin Announces New Annamycin Collaboration in Brain Tumors
About
CEO | Mr. Walter V. Klemp |
CFO | Mr. Jonathan P. Foster CPA |
Address | 5300 Memorial Drive, Houston, TX, United States, 77007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |